Speaker Profile
Biography
Jean leads the JJ multiple autologous and allogenic cell therapies CMC development and due diligence efforts. She was engaged in BCMA and CD 20 CAR-T due diligence and has successfully led the BCMA CAR-T CMC development from phase 1, pivotal, commercial launch and life cycle management. In her role, she also leads and shape the establishing the new platform technologies for cell therapies. Jean joined Janssen Discovery, Product Development Supply (DPDS) in 2016 as the CMC leader and led the allogenic cell therapy late-stage development. Before this, she held technical roles at JJ internal venture and managed a team of scientists working in the area of pluripotent cells scale-up, differentiation and implantable device development. Jean earned her medical degree from Shanghai Medical College of Fudan University and M.S. in Cell and Developmental Biology at Rutgers.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF